A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial

Trials

Nicolas Cherbuin²  George W Rebok¹  Pushpani Herath²  Alex Bahar-Fuchs²  Kaarin J Anstey² 

[1] Department of Mental Health, and the Center on Aging and Health, The Johns Hopkins University, Baltimore, MD, USA;Centre for Research on Ageing Health and Wellbeing, The Australian National University, Canberra, Australia

关键词: Cardiovascular risk factors;    Diet;    Physical activity;    Internet;    Behavior change;    Alzheimer’s disease;    RCT;   

Others  :  1094645
DOI  :  10.1186/1745-6215-14-60

 received in 2012-10-24, accepted in 2013-02-11,  发布年份 2013

【 摘 要 】

Background

Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is also well known that AD-related pathological processes begin more than a decade before the development of clinical signs. These observations suggest that lifestyle interventions might be most effective when targeting non-symptomatic adults at risk of AD. To date, however, the few dementia risk-reduction programs available have targeted individual risk factors and/or were restricted to clinical settings. The current study describes the development of an evidence-based, theoretically-driven multidomain intervention to reduce AD risk in adults at risk.

Method

The design of Body Brain Life (BBL) is a randomized controlled trial (RCT) to evaluate a 12-week online AD risk-reduction intervention. Eligible participants with several modifiable risk factors on the Australian National University (ANU) AD Risk Index (ANU-ADRI) are randomly allocated to an online only group, an online and face-to-face group, or an active control group. We aim to recruit 180 participants, to undergo a comprehensive cognitive and physical assessment at baseline, post-intervention, and 6-month follow-up assessment. The intervention comprises seven online modules (dementia literacy, risk factor education, engagement in physical, social, and cognitive lifestyles, nutrition, and health monitoring) designed using contemporary models of health behavior change.

Discussion

The BBL program is a novel online intervention to reduce the risk of AD in middle-aged adults at risk. The trial is currently under way. It is hypothesized that participants in the intervention arms will make lifestyle changes in several domains, and that this will lead to a reduction in their AD risk profile. We also expect to show that health behavior change is underpinned by changes in psychological determinants of behavior. If successful, the findings will contribute to the development of further dementia risk reduction interventions, and thus contribute to the urgent need to lower dementia risk factors in the population to alter future projections of disease prevalence. Longer follow-up of BBL participants and replications using large samples are required to examine whether reduction in AD risk factors will be associated with reduced prevalence.

Trial registration

Reg. no. ACTRN12612000147886

【 授权许可】

   
2013 Anstey et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Ayaori M, Hisada T, Yoshida H, Shige H, Ito T, Nakajima K, Higashi K, Yonemura A, Ishikawa T, Ohsuzu F, et al.: Effect of alcohol intake on the levels of plasma homocysteine in healthy males. J Nutr Sci Vitaminol 2000, 46:171-174.
• [2]Barnes DE, Yaffe K: The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011, 10:819-828.
• [3]Fratiglioni L, Qiu C: Prevention of cognitive decline in ageing: dementia as the target, delayed onset as the goal. Lancet Neurol 2011, 10:778-779.
• [4]Anstey KJ, Cherbuin N, Budge M, Young J: Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011, 12:e426-e437.
• [5]Anstey KJ, Lipnicki DM, Low LF: Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008, 16:343-354.
• [6]Anstey KJ, Mack HA, Cherbuin N: Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009, 17:542-555.
• [7]Anstey KJ, von Sanden C, Salim A, O’Kearney R: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007, 166:367-378.
• [8]Anstey KJ, Cherbuin N, Herath P: Development of a new method for assessing global risk of alzheimer’s disease for use in population health approaches to prevention. Prev Sci 2013.
• [9]Cherbuin N, Reglade-Meslin C, Kumar R, Jacomb P, Easteal S, Christensen H, Sachdev P, Anstey KJ: Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through life study. Dement Geriatr Cogn Disord 2009, 28:47-55.
• [10]Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CRJ, Kaye J, Wagster MV, Phelps CH: Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011, 7:280-292.
• [11]Hardeman W, Kinmonth AL, Michie S, Sutton S: Impact of a physical activity intervention program on cognitive predictors of behaviour among adults at risk of type 2 diabetes (ProActive randomised controlled trial). Int J Behav Nutr Phys Act 2009, 6:16. BioMed Central Full Text
• [12]Michie S, Abraham C: Interventions to change health behaviours: evidence-based or evidence-inspired? Psychol Health 2004, 19:29-49.
• [13]Michie S, van Stralen MM, West R: The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011, 6:42. BioMed Central Full Text
• [14]Cane J, O’Connor D, Michie S: Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci 2012, 7:37. BioMed Central Full Text
• [15]Michie S, Abraham C, Eccles MP, Francis JJ, Hardeman W, Johnston M: Strengthening evaluation and implementation by specifying components of behaviour change interventions: a study protocol. Implement Sci 2011, 6:10. BioMed Central Full Text
• [16]Ahern DK: Challenges and opportunities of eHealth research. Am J Prev Med 2007, 32:S75-S82.
• [17]Noar SM, Benac CN, Harris MS: Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull 2007, 133:673.
• [18]Portnoy DB, Scott-Sheldon LA, Johnson BT, Carey MP: Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med 2008, 47:3-16.
• [19]Riper H, Spek V, Boon B, Conijn B, Kramer J, Martin-Abello K, Smit F: Effectiveness of E-self-help interventions for curbing adult problem drinking: a meta-analysis. J Med Internet Res 2011, 13:e42.
• [20]Muñoz RF, Aguilera A, Schueller SM, Leykin Y, Pérez-Stable EJ: From online randomized controlled trials to participant preference studies: morphing the San Francisco stop smoking site into a worldwide smoking cessation resource. J Med Internet Res 2012, 14:e64.
• [21]Gatz M, Reynolds CA, John R, Johansson B, Mortimer JA, Pedersen NL: Telephone screening to identify potential dementia cases in a population-based sample of older adults. Int Psychogeriatr 2002, 14:273-289.
• [22]Ketola E, Sipila R, Makela M: Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Ann Med 2000, 32:239-251.
• [23]Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A: Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care 2005, 14:26.
• [24]Low LF, Anstey KJ: Dementia literacy: recognition and beliefs on dementia of the Australian public. Alzheimers Dement 2009, 5:43-49.
• [25]Fielding S, Maclennan G, Cook JA, Ramsay CR: A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials 2008, 9:51. BioMed Central Full Text
• [26]Elobeid MA, Padilla MA, McVie T, Thomas O, Brock DW, Allison DB: Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One 2009, 4:e6624.
• [27]Morrison LG, Yardley L, Powell J, Michie S: What design features are used in effective e-health interventions? A review using techniques from critical interpretive synthesis. Telemed J E Health 2012, 18:137-144.
• [28]Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148:295.